Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori

BACKGROUND: Helicobacter pylori (HP) infection is associated with reduced lung function and systemic inflammation in chronic obstructive pulmonary disease (COPD) patients. Azithromycin (AZ) is active against HP and reduces the risk of COPD exacerbation. We determined whether HP infection status modi...

詳細記述

保存先:
書誌詳細
出版年:Respir Res
主要な著者: Ra, Seung Won, Sze, Marc A., Lee, Eun Chong, Tam, Sheena, Oh, Yeni, Fishbane, Nick, Criner, Gerard J., Woodruff, Prescott G., Lazarus, Stephen C., Albert, Richard, Connett, John E., Han, Meilan K., Martinez, Fernando J., Aaron, Shawn D., Reed, Robert M., Man, S. F. Paul, Sin, Don D.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2017
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5450077/
https://ncbi.nlm.nih.gov/pubmed/28558695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-017-0594-x
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料